ADVICENNE PHARMA is a pharmaceutical company specialized in pediatrics that focuses on the development and commercialization of pediatric drugs for the treatment of neurological diseases and nephrological disorders for which there is still a strong medical need not covered by the treatments currently available on the market.
Development and marketing of drugs for pediatric use or for orphan diseases
Luc-André Granier & Caroline Roussel-Maupetit
IXO intervention: 10,8 M€
Sales figures: 2,7 M€ (2020)
Effective: 33 (2020)